The sCD14-ST predictive value in the development of adverse outcomes in operated colorectal cancer patients (diagnostic study)
Turgunov Y. Ogizbayeva A. Avdiyenko O. Mugazov M. Shakeyev K. Komarov T. Asamidanova S.
1 April 2023Wolters Kluwer Health
Annals of Medicine and Surgery
2023#85Issue 4796 - 801 pp.
Background: The main aim was to analyze dynamic changes in the level of soluble CD14 subtype (sCD14-ST) in blood serum and assess it as a possible risk factor for the development of systemic inflammatory response syndrome, infectious and inflammatory complications, organ dysfunction, and mortality in operated colorectal cancer (CRC) patients. Materials and methods: For the period 2020-2021, 90 operated CRC patients were examined. Patients were divided into two groups: 1 - 50 patients operated on for CRC without acute bowel obstruction (ABO); 2 - 40 patients operated on for tumor ABO caused by CRC. To determine sCD14-ST by the ELISA (enzyme-linked immunosorbent assay) method, venous blood was taken 1 h before surgery and 72 h after it (third day). Results: sCD14-ST levels were higher in CRC patients with ABO, organ dysfunction, and dead patients. If the sCD14-ST level on the third day after surgery is greater than 520 pg/ml, the risk of a fatal outcome is 12.3 times higher than at its lower level [odds ratio (OR): 12.3, 95% CI: 2.34-64.20]. With the increase in the sCD14-ST level on the third day after surgery from baseline or its decrease by no more than 8.8 pg/ml, the risk of organ dysfunctions is 6.5 times higher than with its greater decline (OR: 6.5, 95% CI: 1.66-25.83). Conclusions: This study has demonstrated that in CRC patients, sCD14-ST can be used as a predictive criterion for the development of organ dysfunction and death. Significantly worse results and prognosis were observed in the patients with higher levels of sCD14-ST on the third day after surgery.
colorectal neoplasms , complications , intestinal obstruction , presepsin , sCD14-ST
Text of the article Перейти на текст статьи
Department of Surgical Diseases, Karaganda, Kazakhstan
Department of Emergency Medical Care, Anesthesiology and Resuscitation, Karaganda, Kazakhstan
Research Laboratory of the Institute of Life Sciences, NJSC “Karaganda Medical University”, Karaganda, Kazakhstan
Department of Surgical Diseases
Department of Emergency Medical Care
Research Laboratory of the Institute of Life Sciences
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026